Hybrigenics Mutual Funds

Health Care & Life Sciences » Biotechnology | Hybrigenics

Hybrigenics S.A. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Arcalis

2,067

12/31/2015

View Profile

Address	3-5, impasse Reille Paris Ile-de-France 75014 France
Employees	-
Website	http://www.hybrigenics.com
Updated	07/08/2019
Hybrigenics SA operates as a biopharmaceutical company, which engages in the research and development of targets and therapies against proliferative diseases. It develops inecalcitol for the treatment of prostate cancer, chronic lymphocytic leukemia, and chronic myeloid leukemia. The company was founded on December 29, 1997 and is headquartered in Paris, France.